Skip to content

GORE VIABAHN Endoprosthesis with Heparin VBH091002ARecalls & reported problems

W. L. Gore & Associates, Inc. · VIABAHN SX ENDO HEPARIN 35 9mmX10cm 9Fr 120cmCath · Class 3 · Implant

All models of GORE VIABAHN Endoprosthesis with Heparin (62)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00733132623181), received between Aug 27, 2019 and Aug 27, 2019 — classified as 1 injury.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1

Patient problems

  • Blood Loss1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryAug 27, 2019Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    THE FOLLOWING INFORMATION WAS REPORTED TO GORE: ON (B)(6) 2019 A PATIENT WAS UNDERGOING AN ENDOVASCULAR PROCEDURE. A GORE® EXCLUDER® AAA ENDOPROSTHESIS WAS UTILIZED. TWO GORE® VIABAHN® ENDOPROSTHESES WERE IMPLANTED AND THEN EXPLANTED DURING THE PROCEDURE. ON (B)(6) 2019 IT WAS LEARNED THAT THE DEVICES WERE EXPLANTED IN A CONVERSION TO OPEN REPAIR BECAUSE THERE WAS BLEEDING THAT COULD NOT BE CONTROLLED ENDOVASCULARLY. NO FURTHER INFORMATION IS AVAILABLE.

    Patient problems: Blood Loss

    MAUDE report 8937903 ↗

Other Stent, Superficial Femoral Artery devices

All Stent, Superficial Femoral Artery devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page